Wang Zhen, Lu Junfeng, Zhou Jingwei, Sun Weiwei, Qiu Yang, Chen Weihong, Gao Yabin, Yang Ruibing, Ai Sinan, Liu Zhongjie, Guo Yingbo, Liu Wei Jing, Wang Yaoxian, Peng Liang
Department of Nephrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Renal Research Institution of Beijing University of Chinese Medicine, Beijing, China.
Beijing Key Laboratory for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
Front Microbiol. 2020 Dec 21;11:564376. doi: 10.3389/fmicb.2020.564376. eCollection 2020.
Obesity and related metabolic disorders are associated with intestinal microbiota dysbiosis, disrupted intestinal barrier and chronic inflammation. Shen-Yan-Fang-Shuai formula (SYFSF) is a traditional Chinese herbal formula composed of Astragali Radix, Radix Angelicae Sinensis, Rheum Officinale Baill, and four other herbs. In this study, we identified that SYFSF treatment prevented weight gain, low-grade inflammation and insulin resistance in high-fat diet (HFD)-fed mice. SYFSF also substantially improved gut barrier function, reduced metabolic endotoxemia, as well as systemic inflammation. Sequencing of 16S rRNA genes obtained from fecal samples demonstrated that SYFSF attenuated HFD-induced gut dysbiosis, seen an decreased Firmicutes to Bacteroidetes ratios. Microbial richness and diversity were also higher in the SYFSF-treated HFD group. Furthermore, similar therapeutic effects and changes in gut microbiota profile caused by SYFSF could be replicated by fecal microbiota transfer (FMT). Taken together, our study highlights the efficacy of SYFSF in preventing obesity and related metabolic disorders. Its therapeutic effect is associated with the modulation of gut microbiota, as a prebiotic.
肥胖及相关代谢紊乱与肠道微生物群失调、肠道屏障破坏和慢性炎症有关。肾炎方帅方(SYFSF)是一种由黄芪、当归、大黄和其他四味草药组成的传统中药配方。在本研究中,我们发现SYFSF治疗可预防高脂饮食(HFD)喂养小鼠的体重增加、低度炎症和胰岛素抵抗。SYFSF还显著改善了肠道屏障功能,降低了代谢性内毒素血症以及全身炎症。对粪便样本中获得的16S rRNA基因进行测序表明,SYFSF减轻了HFD诱导的肠道菌群失调,表现为厚壁菌门与拟杆菌门的比例降低。SYFSF治疗的HFD组中微生物的丰富度和多样性也更高。此外,粪便微生物群移植(FMT)可以复制SYFSF所产生的类似治疗效果和肠道微生物群谱变化。综上所述,我们的研究突出了SYFSF在预防肥胖及相关代谢紊乱方面的功效。其治疗效果与作为益生元对肠道微生物群的调节作用有关。